A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia

10.1186/1471-2334-14-530

Saved in:

Bibliographic Details
Main Authors:	Lim, F.S, Koh, M.T, Tan, K.K, Chan, P.C, Chong, C.Y, Shung Yehudi, Y.W, Teoh, Y.L, Shafi, F, Hezareh, M, Swinnen, K, Borys, D
Other Authors:	MEDICINE
Format:	Article
Published:	2020
Subjects:	10 valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine antipyretic agent bacterial vaccine bacterium antibody diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine diphtheria pertussis tetanus Haemophilus influenzae type b vaccine protein D antibody Rotavirus vaccine unclassified drug bacterial polysaccharide bacterial protein carrier protein glpQ protein, Haemophilus influenzae immunoglobulin D lipoprotein Pneumococcus vaccine vaccine antibody titer Article bacterial immunity controlled study coughing diarrhea diphtheria drug safety female fever Haemophilus infection hepatitis B human immunogenicity infant irritability major clinical study Malaysia male multicenter study pain parallel design pertussis phase 3 clinical trial pneumococcal infection poliomyelitis randomized controlled trial rhinorrhea Rotavirus infection side effect Singapore tetanus upper respiratory tract infection urticaria vaccination blood clinical trial immunization immunology Pneumococcal Infections Streptococcus pneumoniae Antibodies, Bacterial Bacterial Proteins Carrier Proteins Female Humans Immunization, Secondary Immunoglobulin D Infant Lipoproteins Male Pneumococcal Vaccines Polysaccharides, Bacterial Vaccination Vaccine Potency Vaccines, Conjugate
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181484
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-181484
record_format	dspace
spelling	sg-nus-scholar.10635-1814842024-04-24T06:51:35Z A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia Lim, F.S Koh, M.T Tan, K.K Chan, P.C Chong, C.Y Shung Yehudi, Y.W Teoh, Y.L Shafi, F Hezareh, M Swinnen, K Borys, D MEDICINE PAEDIATRICS DUKE-NUS MEDICAL SCHOOL 10 valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine antipyretic agent bacterial vaccine bacterium antibody diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine diphtheria pertussis tetanus Haemophilus influenzae type b vaccine protein D antibody Rotavirus vaccine unclassified drug bacterial polysaccharide bacterial protein bacterium antibody carrier protein glpQ protein, Haemophilus influenzae immunoglobulin D lipoprotein Pneumococcus vaccine vaccine antibody titer Article bacterial immunity controlled study coughing diarrhea diphtheria drug safety female fever Haemophilus infection hepatitis B human immunogenicity infant irritability major clinical study Malaysia male multicenter study pain parallel design pertussis phase 3 clinical trial pneumococcal infection poliomyelitis randomized controlled trial rhinorrhea Rotavirus infection side effect Singapore tetanus upper respiratory tract infection urticaria vaccination blood clinical trial immunization immunology Pneumococcal Infections Streptococcus pneumoniae vaccination Antibodies, Bacterial Bacterial Proteins Carrier Proteins Female Humans Immunization, Secondary Immunoglobulin D Infant Lipoproteins Malaysia Male Pneumococcal Infections Pneumococcal Vaccines Polysaccharides, Bacterial Singapore Streptococcus pneumoniae Vaccination Vaccine Potency Vaccines, Conjugate 10.1186/1471-2334-14-530 BMC Infectious Diseases 14 1 530 2020-10-27T11:04:22Z 2020-10-27T11:04:22Z 2014 Article Lim, F.S, Koh, M.T, Tan, K.K, Chan, P.C, Chong, C.Y, Shung Yehudi, Y.W, Teoh, Y.L, Shafi, F, Hezareh, M, Swinnen, K, Borys, D (2014). A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia. BMC Infectious Diseases 14 (1) : 530. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2334-14-530 14712334 https://scholarbank.nus.edu.sg/handle/10635/181484 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	10 valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine antipyretic agent bacterial vaccine bacterium antibody diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine diphtheria pertussis tetanus Haemophilus influenzae type b vaccine protein D antibody Rotavirus vaccine unclassified drug bacterial polysaccharide bacterial protein bacterium antibody carrier protein glpQ protein, Haemophilus influenzae immunoglobulin D lipoprotein Pneumococcus vaccine vaccine antibody titer Article bacterial immunity controlled study coughing diarrhea diphtheria drug safety female fever Haemophilus infection hepatitis B human immunogenicity infant irritability major clinical study Malaysia male multicenter study pain parallel design pertussis phase 3 clinical trial pneumococcal infection poliomyelitis randomized controlled trial rhinorrhea Rotavirus infection side effect Singapore tetanus upper respiratory tract infection urticaria vaccination blood clinical trial immunization immunology Pneumococcal Infections Streptococcus pneumoniae vaccination Antibodies, Bacterial Bacterial Proteins Carrier Proteins Female Humans Immunization, Secondary Immunoglobulin D Infant Lipoproteins Malaysia Male Pneumococcal Infections Pneumococcal Vaccines Polysaccharides, Bacterial Singapore Streptococcus pneumoniae Vaccination Vaccine Potency Vaccines, Conjugate
spellingShingle	10 valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine antipyretic agent bacterial vaccine bacterium antibody diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine diphtheria pertussis tetanus Haemophilus influenzae type b vaccine protein D antibody Rotavirus vaccine unclassified drug bacterial polysaccharide bacterial protein bacterium antibody carrier protein glpQ protein, Haemophilus influenzae immunoglobulin D lipoprotein Pneumococcus vaccine vaccine antibody titer Article bacterial immunity controlled study coughing diarrhea diphtheria drug safety female fever Haemophilus infection hepatitis B human immunogenicity infant irritability major clinical study Malaysia male multicenter study pain parallel design pertussis phase 3 clinical trial pneumococcal infection poliomyelitis randomized controlled trial rhinorrhea Rotavirus infection side effect Singapore tetanus upper respiratory tract infection urticaria vaccination blood clinical trial immunization immunology Pneumococcal Infections Streptococcus pneumoniae vaccination Antibodies, Bacterial Bacterial Proteins Carrier Proteins Female Humans Immunization, Secondary Immunoglobulin D Infant Lipoproteins Malaysia Male Pneumococcal Infections Pneumococcal Vaccines Polysaccharides, Bacterial Singapore Streptococcus pneumoniae Vaccination Vaccine Potency Vaccines, Conjugate Lim, F.S Koh, M.T Tan, K.K Chan, P.C Chong, C.Y Shung Yehudi, Y.W Teoh, Y.L Shafi, F Hezareh, M Swinnen, K Borys, D A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
description	10.1186/1471-2334-14-530
author2	MEDICINE
author_facet	MEDICINE Lim, F.S Koh, M.T Tan, K.K Chan, P.C Chong, C.Y Shung Yehudi, Y.W Teoh, Y.L Shafi, F Hezareh, M Swinnen, K Borys, D
format	Article
author	Lim, F.S Koh, M.T Tan, K.K Chan, P.C Chong, C.Y Shung Yehudi, Y.W Teoh, Y.L Shafi, F Hezareh, M Swinnen, K Borys, D
author_sort	Lim, F.S
title	A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
title_short	A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
title_full	A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
title_fullStr	A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
title_full_unstemmed	A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
title_sort	randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable haemophilus influenzae protein d conjugate vaccine (phid-cv) co-administered with routine childhood vaccines in singapore and malaysia
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/181484
_version_	1800914639485140992

A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia

Similar Items